LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Charite - Universitaetsmedizin Berlin
Headquarters:
Berlin, Germany
Website:
http://www.charite.de/en/cha...
Year Founded:
1710
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Nov 10, 2023
Discovery & Translation
Shinobi’s immune-protected cell therapies; plus Emugen, AZ and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Aug 2, 2023
Discovery & Translation
TRIM11 for tauopathies; plus TCRs that recognize multiple antigens and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Jun 1, 2023
Deals
June 1 Quick Takes: Lonza expands ADC offering with Synaffix takeout
Plus: Owkin investing $50M to build cancer spatial omics consortium and updates from Pfizer, AbbVie, Eikon, Lexicon, Hookipa, AstraZeneca, CMS and more
Read More
BioCentury
|
Sep 28, 2022
Discovery & Translation
Emerald co-founders describe in-home gait sensor to assess Parkinson’s severity and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
Dec 5, 2020
Translation in Brief
James Wilson developing gene therapy version of Regeneron COVID mAb cocktail; plus an oncolytic adenovirus, MapLight-Michael J. Fox Foundation and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
Jan 31, 2020
Distillery Therapeutics
CLEC14A-positive stem cell transplants for muscle regeneration
Read More
BioCentury
|
Dec 17, 2019
ELK1 overexpression for Huntington disease
Read More
BioCentury
|
Sep 19, 2019
Preclinical News
Sept. 19 Preclinical Quick Takes: Celsius' single-cell analysis; plus Merck's RSV therapy, glial cell transplant and methylation profiles for tumors
Read More
BioCentury
|
Oct 29, 2018
Preclinical News
Cas9-reactive Tregs could mitigate Cas9 immunogenicity concerns
Read More
BioCentury
|
May 31, 2018
Emerging Company Profile
Oral route for HAE
Why Pharvaris believes its oral compound can stand out in the crowded HAE field
Read More
Items per page:
10
1 - 10 of 17